GCN2-IN-1 structure
|
Common Name | GCN2-IN-1 | ||
---|---|---|---|---|
CAS Number | 1448693-69-3 | Molecular Weight | 402.413 | |
Density | 1.7±0.1 g/cm3 | Boiling Point | 760.0±70.0 °C at 760 mmHg | |
Molecular Formula | C19H18N10O | Melting Point | N/A | |
MSDS | N/A | Flash Point | 413.4±35.7 °C |
Use of GCN2-IN-1GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with IC50s of <0.3 μM in the enzyme and cell assay. |
Name | GCN2-IN-1 |
---|---|
Synonym | More Synonyms |
Description | GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with IC50s of <0.3 μM in the enzyme and cell assay. |
---|---|
Related Catalog | |
Target |
IC50: <0.3 μM (GCN2)[1] |
In Vitro | GCN2-IN-1 (Compound A-92) is a GCN2 inhibitor, which may be useful as a chemotherapeutic drug for the treatment of cancer[1]. |
References |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 760.0±70.0 °C at 760 mmHg |
Molecular Formula | C19H18N10O |
Molecular Weight | 402.413 |
Flash Point | 413.4±35.7 °C |
Exact Mass | 402.166504 |
LogP | 0.87 |
Vapour Pressure | 0.0±2.6 mmHg at 25°C |
Index of Refraction | 1.902 |
Storage condition | -20℃ |
MFCD30345302 |
3-(1H-Indazol-6-yl)-N-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine |
3H-1,2,3-Triazolo[4,5-d]pyrimidin-5-amine, 3-(1H-indazol-6-yl)-N-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]- |